Current:Home > FinancePoinbank Exchange|Trump signals support for reclassifying pot as a less dangerous drug, in line with Harris’ position -Quantum Capital Pro
Poinbank Exchange|Trump signals support for reclassifying pot as a less dangerous drug, in line with Harris’ position
Oliver James Montgomery View
Date:2025-04-08 00:10:56
▶ Follow the AP’s live coverage and Poinbank Exchangeanalysis as Donald Trump and Kamala Harris prep for their first debate.
WASHINGTON (AP) — Donald Trump has signaled support for a potentially historic federal policy shift to reclassify marijuana as a less dangerous drug, putting his position in line with that of his Democratic opponent, Kamala Harris.
The commonality reflects a major shift toward broad public support for legalization in recent years and marks the first time that both major-party presidential candidates support broad cannabis reform, according to the U.S. Cannabis Council.
The Republican presidential nominee posted on his social media platform late Sunday that he would “continue to focus on research to unlock the medical uses of marijuana to a Schedule 3 drug,” and also said he would be voting “yes” on a proposal to allow the sale of marijuana to adults for any reason in Florida.
Coming shortly before the two will meet for a pivotal debate, Trump’s post sets up the possibility that he could criticize Harris for her past cannabis prosecutions when she was district attorney in San Francisco. Because drug prosecutions disproportionately affect nonwhite defendants in the U.S., the line of attack could also fit with Trump’s efforts to increase his support among nonwhite men.
Harris backs decriminalization and has called it “absurd” that the Drug Enforcement Administration now has marijuana in the Schedule I category alongside heroin and LSD. Earlier in her career, she oversaw the enforcement of cannabis laws and opposed legalized recreational use for adults in California while running for attorney general in 2010.
Harris has absorbed attacks on her prosecutorial record on the debate stage before, most notably from Democrat-turned-Trump supporter Tulsi Gabbard, who ran for the Democratic presidential nomination in 2020 and announced in 2022 that she was leaving the party.
Trump said during his 2016 run that pot policy should be left up the states. During his term in the White House, though, then-Attorney General Jeff Sessions lifted an Obama-era policy that kept federal authorities from cracking down on the marijuana trade in states where the drug is legal.
The DEA process to change the drug’s federal classification is already underway, kickstarted by President Joe Biden’s call for a review. But the DEA hasn’t made a final decision on the shift, which would not legalize recreational marijuana outright. It may not decide until the next presidential administration, putting a spotlight on the candidates’ positions.
Federal drug policy has lagged behind that of many states in recent years, with 38 having already legalized medical marijuana and 24 legalizing recreational use.
About 70% of adults supported legalization in a Gallup poll taken last year, the highest level yet recorded by the polling firm and more than double the roughly 3 in 10 who backed it in 2000. Support was even higher among young voters, a key demographic in seven main battleground states.
“We believe cannabis reform is a winning issue,” said David Culver, senior vice president of public affairs at the U.S. Cannabis Council, in a statement Monday.
The federal policy shift would wouldn’t legalize marijuana outright for recreational use. Instead, it would move marijuana out of Schedule I to the Schedule III category, alongside ketamine and some anabolic steroids.
The proposed shift is facing opposition from advocates who say there isn’t enough data and from attorneys general in more than a dozen states, according to the group Smart Approaches to Marijuana.
___
Associated Press writer Bill Barrow in Atlanta contributed to this report.
veryGood! (8)
Related
- The FBI should have done more to collect intelligence before the Capitol riot, watchdog finds
- How Much Damage are Trump’s Solar Tariffs Doing to the U.S. Industry?
- Has the Ascend Nylon Plant in Florida Cut Its Greenhouse Gas Emissions, as Promised? A Customer Wants to Know
- Alabama Town That Fought Coal Ash Landfill Wins Settlement
- Most popular books of the week: See what topped USA TODAY's bestselling books list
- Key Question as Exxon Climate Trial Begins: What Did Investors Believe?
- Vanderpump Rules Reunion: Tom Sandoval and Raquel Leviss Confess They’re Still in Love
- Wednesday's Percy Hynes White Denies Baseless, Harmful Misconduct Accusations
- McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
- Read full text of Supreme Court student loan forgiveness decision striking down Biden's debt cancellation plan
Ranking
- Megan Fox's ex Brian Austin Green tells Machine Gun Kelly to 'grow up'
- California library uses robots to help kids with autism learn and connect with the world around them
- Vanderpump Rules Reunion: Tom Sandoval and Raquel Leviss' Affair Comes to a Shocking Conclusion
- Louisville Zoo elephant calf named Fitz dies at age 3 following virus
- 'Most Whopper
- New York Assembly Approves Climate Bill That Would Cut Emissions to Zero
- U.S. Wind Power Is ‘Going All Out’ with Bigger Tech, Falling Prices, Reports Show
- No major flight disruptions from new 5G wireless signals around airports
Recommendation
Justice Department, Louisville reach deal after probe prompted by Breonna Taylor killing
Dakota Pipeline Fight Is Sioux Tribe’s Cry For Justice
Chemours Says it Will Dramatically Reduce Greenhouse Gas Emissions, Aiming for Net Zero by 2050
Vanderpump Rules' Raquel Leviss Turns on Tom Sandoval and Reveals Secret He Never Wanted Out
Meet the volunteers risking their lives to deliver Christmas gifts to children in Haiti
Biden’s Climate Credibility May Hinge on Whether He Makes Good on U.S. Financial Commitments to Developing Nations
New York Assembly Approves Climate Bill That Would Cut Emissions to Zero
Wendy Williams Receiving Treatment at Wellness Facility